APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment

INTRODUCTION: Alzheimer’s disease brains are characterized by extracellular plaques containing the aggregated amyloid β(42) (Aβ(42)) peptide and intraneuronal tangles containing hyperphosphorylated tau. Aβ(42) is produced by sequential processing of the amyloid precursor protein (APP) by β-secretase...

Descripción completa

Detalles Bibliográficos
Autores principales: Sjödin, Simon, Andersson, Kerstin K. A., Mercken, Marc, Zetterberg, Henrik, Borghys, Herman, Blennow, Kaj, Portelius, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687145/
https://www.ncbi.nlm.nih.gov/pubmed/26689589
http://dx.doi.org/10.1186/s13195-015-0160-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687145/
https://www.ncbi.nlm.nih.gov/pubmed/26689589
http://dx.doi.org/10.1186/s13195-015-0160-z

Ejemplares similares